Health Focus Triggers Demand Shift in Food Industry
2023 revealed the dramatic influence of health-focused pharmaceuticals on consumer food choices. Semaglutide (Ozempic, Wegovy) by Novo Nordisk and Eli Lilly’s Tirzepatide (Mounjaro)1 layed pivotal roles. By highlighting the health consequences of certain foods in diabetes management and weight loss, they spurred a notable decline in demand for unhealthy food products. This shift impacted traditional food and animal-agriculture based companies’ share prices, aligning with our investment approach that excludes investments in such firms.
COP28 Spurs Pivotal Global Food Initiatives
COP28 marked a significant turn in addressing food systems within climate action. Key highlights included the Global Stocktake acknowledging food’s critical role in climate response and the launch of the Alliance of Champions for Food Systems Transformation (ACF2) led by countries like Norway and Brazil. These initiatives underscored the urgency of sustainable agricultural practices and climate-resilient food production.
UN FAO’s Transformative Roadmap
The UN Food and Agriculture Organization’s roadmap, unveiled at COP28, is set to revolutionise agrifood systems, targeting their transition to carbon sinks by 2050. By focusing on areas like livestock and crop practices, the plan aligns with the Paris Agreement’s 1.5-degree limit and aims to eradicate world hunger.3
Netflix’s ‘You Are What You Eat’ Catalyses Consumer Awareness
Netflix’s documentary ‘You Are What You Eat’, released in January 2024, highlights the significant impact of diet on health and environment. Featuring an experiment with identical twins, it vividly demonstrates how different diets affect physical and mental health. This series is expected to amplify consumer awareness in the US and globally, encouraging a shift towards sustainable food choices. Its alignment with the FAO’s roadmap symbolises a key moment in progressing towards sustainable, health-focused food systems.4